Today the GuruFocus Guru Bargains feature reveals four stocks that are 40% or more off since a number of billionaires bought them. It provides some level of assurance to be able to follow or at least consider the pathway of billionaire investors who’ve already put their money on these stocks. Billionaire buys can indicate a probability that certain stocks may have deep value. Check out the GuruFocus Guru Bargains feature to discover many more stocks priced at around 20% off since billionaires last bought.
Primus Telecommunications Group Inc. (PTGI) - Yield 0.00%
Primus Telecommunications Group Inc. is down 73% over 12 months. The current share price is $3.8, down 68% since Mario Gabelli added 72.41% to his position as of June 30, 2013.
As of June 30, 2013, Guru Gabelli bought 21,000 shares at an average price of $11.88 for a loss of 68%. He has held for two quarters, also losing 65.9% in the previous quarter.
His current shares are 50,000.
Formed in 1994, Primus Telecommunications Group Inc. is an integrated facilities-based communications services provider offering a portfolio of international and domestic voice, wireless, Internet, VoIP, data, colocation and data center services mainly in Australia, Canada, and the United States.
The company has a market cap of $53.07 million; its trades with a P/E ratio of 1.70 and a P/B ratio of 0.80.
In May the company reported first quarter 2013 net revenue of $60.9 million, a decrease of 10% from the same quarter in 2012. The company reported a net loss of $3.2 million, compared to a loss of $6.9 million in the same quarter of 2012. The adjusted EBITDA was $9.4 million compared to $9.0 million in the first quarter of 2012.
Tracking historical share pricing, revenue and net income:
Check out four Guru Stakeholders as of June 30, 2013.
Homex Development Corp. (HXM) - Yield 0.00%
Homex Development Corp. is down 82% over 12 months. The current share price is around $2.43, down 48% since Charles Brandes added 101.65% to his position as of May 31, 2013, when he bought 226,160 shares at an average price of $12.62 for a loss of 80.7%. He has held for three quarters, also losing around 80% or more in the previous quarters.
His current shares are 804,219.
Incorporated in Mexico in 1998, Homex Development Corp. is an integrated home development company engaged in the development, construction and sale of affordable entry-level, middle-income and tourism housing in Mexico and affordable entry-level housing in Brazil.
The company has a market cap of $135.62 million; its trades with a P/E ratio of 2.10 and a P/B ratio of 0.30.
In July, the company reported a second quarter 2013 loss of $782 million.
Tracking historical share pricing, revenue and net income:
Check out five Guru stakeholders as of June 30, 2013.
Dex Media Inc. (DXM) - Yield 0.00%
Dex Media Inc. is down 14% over 12 months. The current share price is around $9.79, down 43% since John Paulson added 18.75% to his position as of May 16, 2013, when he bought 2,231,132 shares at an average price of $17.63 for a loss of 444.5%. This was his first quarter of holding.
His current shares are 2,231,132.
Incorporated in 2012 for the purpose of facilitating the merger of Dex One Corporation and SuperMedia Inc., Dex Media Inc. is a provider of social, local and mobile marketing solutions that include websites, print, mobile, search engine and social media solutions for local businesses through its Dex One and SuperMedia Marketing Consultants.
The company has a market cap of $171.01 million.
According to a company statement, the merger of Dex One and SuperMedia was consummated on April 30, 2013, with 100% of the equity of SuperMedia being exchanged for equity in Dex Media. For the three months ending June 30, 2013, Dex Media Inc.’s consolidated statement of operations reported a 3% increase in operating revenue of $345 million compared to $335 million in the same quarter of 2012. The company’s net income for the same quarter shows a $68 million loss, compared to last year’s net income of $53 million.
Historical pricing:
A total of four Guru stakeholders hold DXM as of June 30, 2013.
Enzon Pharmaceuticals Inc. (ENZN) - Yield 0.00%
Enzon Pharmaceuticals Inc. is down 74% over 12 months. The current share price is around $1.76, down 40% since Charles Brandes added 184.52% to his position as of June 30, 2013, when he bought 665,858 shares at an average price of $2.93 for a loss of 39.2%. He has held for six consecutive quarters, all losing double digits.
His current shares are 1,026,723.
Enzon Pharmaceuticals Inc. is a biotechnology company, founded in 1981. The company is engaged in the research and development of therapeutic drug development for cancer patients primarily in the U.S.
The company has a market cap of $78.6 million; its trades with a P/E ratio of 17.30 and a P/B ratio of 0.90.
In June 2013, Belrose Pharma, a specialty pharmaceutical company, announced the acquisition of Enzon Pharmaceutical's PEGylation Linker Technology (Customized Linker Technology®) platform and associated product pipeline.
Enzon receives royalty revenues on seven marketed products that utilize its proprietary technology. Revenues received from the company's royalty products for the three months ended December 31, 2012 were $10.5 million, compared to $9.8 million for the three months ended December 31, 2011. For the full year 2012, royalty revenues were $41.5 million, compared to $40.9 million for the full year 2011, according to a company press release.
Six Gurus hold ENZN as of June 30, 2013.
If you are not yet a Premium Member, try a 7-day Free Trial.
GuruFocus Real Time Picks reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the transaction. This feature is for Premium Members only.
Check out the Guru Focus special feature 52-week low screener to find the stocks hitting new lows but are still held by top investor Gurus and Insiders.
Primus Telecommunications Group Inc. (PTGI) - Yield 0.00%
Primus Telecommunications Group Inc. is down 73% over 12 months. The current share price is $3.8, down 68% since Mario Gabelli added 72.41% to his position as of June 30, 2013.
As of June 30, 2013, Guru Gabelli bought 21,000 shares at an average price of $11.88 for a loss of 68%. He has held for two quarters, also losing 65.9% in the previous quarter.
His current shares are 50,000.
Formed in 1994, Primus Telecommunications Group Inc. is an integrated facilities-based communications services provider offering a portfolio of international and domestic voice, wireless, Internet, VoIP, data, colocation and data center services mainly in Australia, Canada, and the United States.
The company has a market cap of $53.07 million; its trades with a P/E ratio of 1.70 and a P/B ratio of 0.80.
In May the company reported first quarter 2013 net revenue of $60.9 million, a decrease of 10% from the same quarter in 2012. The company reported a net loss of $3.2 million, compared to a loss of $6.9 million in the same quarter of 2012. The adjusted EBITDA was $9.4 million compared to $9.0 million in the first quarter of 2012.
Tracking historical share pricing, revenue and net income:
Check out four Guru Stakeholders as of June 30, 2013.
Homex Development Corp. (HXM) - Yield 0.00%
Homex Development Corp. is down 82% over 12 months. The current share price is around $2.43, down 48% since Charles Brandes added 101.65% to his position as of May 31, 2013, when he bought 226,160 shares at an average price of $12.62 for a loss of 80.7%. He has held for three quarters, also losing around 80% or more in the previous quarters.
His current shares are 804,219.
Incorporated in Mexico in 1998, Homex Development Corp. is an integrated home development company engaged in the development, construction and sale of affordable entry-level, middle-income and tourism housing in Mexico and affordable entry-level housing in Brazil.
The company has a market cap of $135.62 million; its trades with a P/E ratio of 2.10 and a P/B ratio of 0.30.
In July, the company reported a second quarter 2013 loss of $782 million.
Tracking historical share pricing, revenue and net income:
Check out five Guru stakeholders as of June 30, 2013.
Dex Media Inc. (DXM) - Yield 0.00%
Dex Media Inc. is down 14% over 12 months. The current share price is around $9.79, down 43% since John Paulson added 18.75% to his position as of May 16, 2013, when he bought 2,231,132 shares at an average price of $17.63 for a loss of 444.5%. This was his first quarter of holding.
His current shares are 2,231,132.
Incorporated in 2012 for the purpose of facilitating the merger of Dex One Corporation and SuperMedia Inc., Dex Media Inc. is a provider of social, local and mobile marketing solutions that include websites, print, mobile, search engine and social media solutions for local businesses through its Dex One and SuperMedia Marketing Consultants.
The company has a market cap of $171.01 million.
According to a company statement, the merger of Dex One and SuperMedia was consummated on April 30, 2013, with 100% of the equity of SuperMedia being exchanged for equity in Dex Media. For the three months ending June 30, 2013, Dex Media Inc.’s consolidated statement of operations reported a 3% increase in operating revenue of $345 million compared to $335 million in the same quarter of 2012. The company’s net income for the same quarter shows a $68 million loss, compared to last year’s net income of $53 million.
Historical pricing:
A total of four Guru stakeholders hold DXM as of June 30, 2013.
Enzon Pharmaceuticals Inc. (ENZN) - Yield 0.00%
Enzon Pharmaceuticals Inc. is down 74% over 12 months. The current share price is around $1.76, down 40% since Charles Brandes added 184.52% to his position as of June 30, 2013, when he bought 665,858 shares at an average price of $2.93 for a loss of 39.2%. He has held for six consecutive quarters, all losing double digits.
His current shares are 1,026,723.
Enzon Pharmaceuticals Inc. is a biotechnology company, founded in 1981. The company is engaged in the research and development of therapeutic drug development for cancer patients primarily in the U.S.
The company has a market cap of $78.6 million; its trades with a P/E ratio of 17.30 and a P/B ratio of 0.90.
In June 2013, Belrose Pharma, a specialty pharmaceutical company, announced the acquisition of Enzon Pharmaceutical's PEGylation Linker Technology (Customized Linker Technology®) platform and associated product pipeline.
Enzon receives royalty revenues on seven marketed products that utilize its proprietary technology. Revenues received from the company's royalty products for the three months ended December 31, 2012 were $10.5 million, compared to $9.8 million for the three months ended December 31, 2011. For the full year 2012, royalty revenues were $41.5 million, compared to $40.9 million for the full year 2011, according to a company press release.
Six Gurus hold ENZN as of June 30, 2013.
If you are not yet a Premium Member, try a 7-day Free Trial.
GuruFocus Real Time Picks reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the transaction. This feature is for Premium Members only.
Check out the Guru Focus special feature 52-week low screener to find the stocks hitting new lows but are still held by top investor Gurus and Insiders.
